{"id":"W2883187082","doi":"10.1016/j.cgh.2018.07.009","title":"Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis","year":2018,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Centre for Mathematical Cognition, Loughborough University; Ferring Pharmaceuticals; MedImmune; Eisai; Gilead Sciences; Celgene; Shire; AstraZeneca; Takeda Pharmaceuticals U.S.A.; School of Public Health, University of California Berkeley; Dr. Falk Pharma; Pfizer; Amgen; Celltrion; AbbVie; Schering-Plough; Meso Scale Diagnostics; Abbott Laboratories","keywords":"Tofacitinib; Medicine; Placebo; Ulcerative colitis; Internal medicine; Janus kinase inhibitor; Gastroenterology; Clinical endpoint; Randomized controlled trial; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002946066,0.0001915395,0.0003003397,0.0000366622,0.0001666233,0.00001219111,0.0001268041,0.0003192548,0.00003342337],"category_scores_gemma":[0.0001333858,0.0001574667,0.00007913234,0.00002359393,0.001309978,0.000008914737,0.00006496683,0.0001421182,0.000006308421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007178265,"about_ca_system_score_gemma":0.0000756486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002135813,"about_ca_topic_score_gemma":0.0001901516,"domain_scores_codex":[0.9982885,0.0003333411,0.0004188917,0.0005553865,0.00005532677,0.0003485168],"domain_scores_gemma":[0.9990963,0.00004658941,0.0002073264,0.000230278,0.000271136,0.0001483439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02035525,0.000242067,0.9758844,0.00000650875,0.0001948659,0.000006186029,0.00005692032,4.291157e-7,0.0001564832,0.0002856736,0.001081428,0.001729773],"study_design_scores_gemma":[0.005714125,0.01105397,0.978195,0.000007526916,0.00003866537,0.0000254152,0.00003617779,0.00003259009,0.0005734714,0.0002169364,0.003969221,0.0001369211],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979976,0.00001503641,0.0004882722,0.0002297698,0.0005895321,0.0004800369,0.00009311865,0.00001797517,0.00008866156],"genre_scores_gemma":[0.9959865,0.00004451753,0.0006238238,0.002431175,0.0004759167,0.0001163223,0.0002410912,0.00002133623,0.00005928323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01464113,"threshold_uncertainty_score":0.6421307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01776128191355194,"score_gpt":0.2963944256288678,"score_spread":0.2786331437153159,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}